Cargando…

Identification of Master Regulators Driving Disease Progression, Relapse, and Drug Resistance in Lung Adenocarcinoma

Backgrounds: Lung cancer is the leading cause of cancer related death worldwide. Current treatment strategies primarily involve surgery, chemotherapy, radiotherapy, targeted therapy, and immunotherapy, determined by TNM stages, histologic types, and genetic profiles. Plenty of studies have been tryi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Qiong, Cha, Qiongfang, Qin, Hui, Liu, Bin, Wu, Xueling, Shi, Jiantao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Bioinformatics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580914/ https://www.ncbi.nlm.nih.gov/pubmed/36304306 http://dx.doi.org/10.3389/fbinf.2022.813960

Ejemplares similares

Signature identification of relapse-related overall survival of early lung adenocarcinoma after radical surgery
por: Han, Peng, et al.
Publicado: (2021)

Identification of KIF4A and its effect on the progression of lung adenocarcinoma based on the bioinformatics analysis
por: Song, Yexun, et al.
Publicado: (2021)

Identification of a novel autophagy signature for predicting survival in patients with lung adenocarcinoma
por: Duan, Jin, et al.
Publicado: (2021)

Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma
por: Yue, Cheng, et al.
Publicado: (2019)

Identification of an immune prognostic 11-gene signature for lung adenocarcinoma
por: Yang, Tao, et al.
Publicado: (2021)

Identification of a circadian gene signature that predicts overall survival in lung adenocarcinoma
por: Gao, Xinliang, et al.
Publicado: (2021)

Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma
por: Xu, Zhan-yu, et al.
Publicado: (2020)

Multiple genome pattern analysis and signature gene identification for the Caucasian lung adenocarcinoma patients with different tobacco exposure patterns
por: Dong, Yan-mei, et al.
Publicado: (2020)

Genome-wide analysis of the hypoxia-related DNA methylation-driven genes in lung adenocarcinoma progression
por: Li, Hongxia, et al.
Publicado: (2020)

Identification of a putative competitive endogenous RNA network for lung adenocarcinoma using TCGA datasets
por: Wang, Yuanyong, et al.
Publicado: (2019)

Identification of a ferroptosis-related gene signature (FRGS) for predicting clinical outcome in lung adenocarcinoma
por: Wang, Sheng, et al.
Publicado: (2021)

Identification of a six-gene metabolic signature predicting overall survival for patients with lung adenocarcinoma
por: Cao, Yubo, et al.
Publicado: (2020)

Identification of HMMR as a prognostic biomarker for patients with lung adenocarcinoma via integrated bioinformatics analysis
por: Li, Zhaodong, et al.
Publicado: (2021)

Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches
por: Jiang, Jing, et al.
Publicado: (2023)

Predicting lung adenocarcinoma disease progression using methylation-correlated blocks and ensemble machine learning classifiers
por: Yu, Xin, et al.
Publicado: (2021)

Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets
por: Ren, Na, et al.
Publicado: (2020)

Identification of key genes associated with progression and prognosis for lung squamous cell carcinoma
por: Ma, Xiaohan, et al.
Publicado: (2020)

Identification of an immune-related six-long noncoding RNA signature as a novel prognosis biomarker for adenocarcinoma of lung
por: Miao, Huikai, et al.
Publicado: (2021)

Identification of candidate genes and prognostic value analysis in patients with PDL1-positive and PDL1-negative lung adenocarcinoma
por: Qi, Xiaoguang, et al.
Publicado: (2020)

Construction and validation of a 15-gene ferroptosis signature in lung adenocarcinoma
por: Tu, Guangxu, et al.
Publicado: (2021)

Identification of four hub genes associated with adrenocortical carcinoma progression by WGCNA
por: Xia, Wang-Xiao, et al.
Publicado: (2019)

Identification of P2RY13 as an immune-related prognostic biomarker in lung adenocarcinoma: A public database-based retrospective study
por: Lin, Jiang, et al.
Publicado: (2021)

High expression of PIMREG predicts poor survival outcomes and is correlated with immune infiltrates in lung adenocarcinoma
por: Jiang, Feng, et al.
Publicado: (2021)

Development of an autophagy-related gene prognostic signature in lung adenocarcinoma and lung squamous cell carcinoma
por: Zhu, Jie, et al.
Publicado: (2020)

Bioinformatics analysis of microarray data to identify the candidate biomarkers of lung adenocarcinoma
por: Guo, Tingting, et al.
Publicado: (2019)

CKS2 and RMI2 are two prognostic biomarkers of lung adenocarcinoma
por: Xiao, Dayong, et al.
Publicado: (2020)

Prognostic model of AU-rich genes predicting the prognosis of lung adenocarcinoma
por: Liu, Yong, et al.
Publicado: (2021)

High expression of MCM10 is predictive of poor outcomes in lung adenocarcinoma
por: Shao, Mingrui, et al.
Publicado: (2021)

Tumor microenvironment related novel signature predict lung adenocarcinoma survival
por: Chen, Juan, et al.
Publicado: (2021)

The hypoxia-associated genes in immune infiltration and treatment options of lung adenocarcinoma
por: Liu, Liu, et al.
Publicado: (2023)

Identification of prognostic splicing factors and exploration of their potential regulatory mechanisms in pancreatic adenocarcinoma
por: Rong, Min-hua, et al.
Publicado: (2020)

Driver gene alterations profiling of Chinese non‐small cell lung cancer and the effects of co‐occurring alterations on immunotherapy
por: Sun, Shengjie, et al.
Publicado: (2021)

Integrated analysis of the roles and prognostic value of RNA binding proteins in lung adenocarcinoma
por: Li, Wei, et al.
Publicado: (2020)

Two predicted models based on ceRNAs and immune cells in lung adenocarcinoma
por: Zhang, Miaomiao, et al.
Publicado: (2021)

Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma
por: Li, Wanzhen, et al.
Publicado: (2021)

The correlation of WDR76 expression with survival outcomes and immune infiltrates in lung adenocarcinoma
por: Fang, Likui, et al.
Publicado: (2021)

Establishment of a ferroptosis-related gene signature for prognosis in lung adenocarcinoma patients
por: Cai, Jingjing, et al.
Publicado: (2021)

Integrated analysis reveals five potential ceRNA biomarkers in human lung adenocarcinoma
por: Liu, Yu, et al.
Publicado: (2019)

FGL2 is positively correlated with enhanced antitumor responses mediated by T cells in lung adenocarcinoma
por: Yuan, Kai, et al.
Publicado: (2020)

Homologous recombination repair rathway and RAD54L in early-stage lung adenocarcinoma
por: Zheng, Shaopeng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ip549httilrfkurt83unev10ua